T1	PROC 77 88	tratamiento
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	CHEM 252 259	agentes
#2	AnnotatorNotes T2	C0450442; Agent; Chemical Viewed Functionally
T3	PROC 283 329	Protocolo de extensión, multicéntrico, abierto
T4	PROC 477 488	monoterapia
#3	AnnotatorNotes T4	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T5	PROC 516 545	tratamientos en investigación
#4	AnnotatorNotes T5	C0949266; Therapies, Investigational; Therapeutic or Preventive Procedure
T6	DISO 569 575	cáncer
#5	AnnotatorNotes T6	C0006826; Malignant Neoplasms; Neoplastic Process
T7	PROC 816 827	monoterapia
#6	AnnotatorNotes T7	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T8	PROC 855 884	tratamientos en investigación
#7	AnnotatorNotes T8	C0949266; Therapies, Investigational; Therapeutic or Preventive Procedure
T9	CHEM 802 812	ribociclib
#8	AnnotatorNotes T9	C4045494; ribociclib; Organic Chemical · Pharmacologic Substance
T10	PROC 959 970	tratamiento
#9	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	PROC 1060 1069	protocolo
#10	AnnotatorNotes T11	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T12	PROC 1220 1229	protocolo
#11	AnnotatorNotes T12	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T13	PROC 1307 1316	protocolo
#12	AnnotatorNotes T13	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T14	PROC 1332 1356	continuar el tratamiento
#13	AnnotatorNotes T14	C2091305; continue current medication; Therapeutic or Preventive Procedure
T15	CHEM 145 151	LEE011
#14	AnnotatorNotes T15	C2987342; LEE011; Organic Chemical · Pharmacologic Substance
T16	CHEM 209 219	ribociclib
#15	AnnotatorNotes T16	C4045494; ribociclib; Organic Chemical · Pharmacologic Substance
T17	CHEM 384 394	ribociclib
#16	AnnotatorNotes T17	C4045494; ribociclib; Organic Chemical · Pharmacologic Substance
T18	CHEM 396 402	LEE011
#17	AnnotatorNotes T18	C2987342; LEE011; Organic Chemical · Pharmacologic Substance
T19	CHEM 463 473	ribociclib
#18	AnnotatorNotes T19	C4045494; ribociclib; Organic Chemical · Pharmacologic Substance
T20	DISO 622 628	cáncer
#19	AnnotatorNotes T20	C0006826; Malignant Neoplasms; Neoplastic Process
T21	CHEM 736 746	ribociclib
#20	AnnotatorNotes T21	C4045494; ribociclib; Organic Chemical · Pharmacologic Substance
T22	CHEM 748 754	LEE011
#21	AnnotatorNotes T22	C2987342; LEE011; Organic Chemical · Pharmacologic Substance
T23	CHEM 1194 1204	ribociclib
#22	AnnotatorNotes T23	C4045494; ribociclib; Organic Chemical · Pharmacologic Substance
T24	CHEM 1206 1212	LEE011
#23	AnnotatorNotes T24	C2987342; LEE011; Organic Chemical · Pharmacologic Substance
T25	Date 13 17	2016
T26	LIVB 108 117	pacientes
#24	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	LIVB 335 344	pacientes
#25	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	LIVB 666 675	Pacientes
#26	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	Date 680 691	actualmente
T30	LIVB 888 897	Pacientes
#27	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Date 902 913	actualmente
T32	LIVB 1003 1015	investigador
#28	AnnotatorNotes T32	C0035173; Research Personnel; Professional or Occupational Group
T33	LIVB 1019 1028	Pacientes
#29	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	LIVB 1105 1117	investigador
#30	AnnotatorNotes T34	C0035173; Research Personnel; Professional or Occupational Group
T35	LIVB 1147 1156	Pacientes
#31	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T37	LIVB 1264 1273	Pacientes
#32	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T36	PROC 1167 1193	suspendido permanentemente
#33	AnnotatorNotes T36	C0850893; stop medication; Therapeutic or Preventive Procedure (?)
#34	AnnotatorNotes T29	C0521116; Current (present time); Temporal Concept 
#35	AnnotatorNotes T31	C0521116; Current (present time); Temporal Concept 
T38	Neg_cue 1278 1280	no
T39	Observation 1281 1302	cumplan los criterios
A1	Assertion T39 Negated
#36	AnnotatorNotes T39	C1302261; Patient eligible for clinical trial; Finding (?)
T40	Quantifier_or_Qualifier 629 637	avanzado
#37	AnnotatorNotes T40	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R1	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T40	
R2	Experiences Arg1:T26 Arg2:T1	
R3	Used_for Arg1:T15 Arg2:T1	
R4	Used_for Arg1:T16 Arg2:T1	
R5	Experiences Arg1:T26 Arg2:T16	
R6	Combined_with Arg1:T16 Arg2:T2	
R7	Combined_with Arg1:T15 Arg2:T2	
T41	Quantifier_or_Qualifier 220 224	solo
R8	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T41	
R9	Experiences Arg1:T26 Arg2:T2	
T42	CONC 58 73	acceso continuo
T43	Observation 349 380	hayan participado en un estudio
#38	AnnotatorNotes T43	C1278516; Patient participationstatus; Finding (?)
R11	Experiences Arg1:T27 Arg2:T17	
R12	Experiences Arg1:T27 Arg2:T18	
R13	Experiences Arg1:T27 Arg2:T19	
R14	Used_for Arg1:T19 Arg2:T4	
R15	Combined_with Arg1:T19 Arg2:T5	
R16	Used_for Arg1:T18 Arg2:T4	
R17	Used_for Arg1:T17 Arg2:T4	
R18	Combined_with Arg1:T17 Arg2:T5	
R19	Combined_with Arg1:T18 Arg2:T5	
R20	Experiences Arg1:T27 Arg2:T5	
R21	Overlap Arg1:T21 Arg2:T29	
R22	Overlap Arg1:T22 Arg2:T29	
T44	Observation 698 721	incluidos en un estudio
#39	AnnotatorNotes T44	C1278516; Patient participationstatus; Finding (?)
R23	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T44	
R24	Overlap Arg1:T44 Arg2:T29	
R27	Used_for Arg1:T9 Arg2:T7	
R30	Combined_with Arg1:T21 Arg2:T8	
R31	Combined_with Arg1:T22 Arg2:T8	
R32	Combined_with Arg1:T9 Arg2:T8	
R33	Experiences Arg1:T28 Arg2:T21	
R34	Experiences Arg1:T28 Arg2:T22	
R35	Experiences Arg1:T28 Arg2:T9	
R36	Experiences Arg1:T28 Arg2:T8	
T45	Observation 937 954	beneficio clínico
#40	AnnotatorNotes T45	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R37	Experiences Arg1:T30 Arg2:T45	
R38	Overlap Arg1:T45 Arg2:T31	
R39	Causes Arg1:T10 Arg2:T45	
R40	Overlap Arg1:T10 Arg2:T31	
R41	Experiences Arg1:T30 Arg2:T10	
T46	Observation 1033 1069	cumplan los requisitos del protocolo
R43	Experiences Arg1:T35 Arg2:T36	
R44	Used_for Arg1:T23 Arg2:T36	
R45	Used_for Arg1:T24 Arg2:T36	
R47	Negation Arg1:T38 Arg2:T39	
R48	Before Arg1:T39 Arg2:T14	
R49	Experiences Arg1:T37 Arg2:T14	
#41	AnnotatorNotes T41	C0205171; Singular; Quantitative Concept
A2	Experiencer T26 Patient
A3	Experiencer T27 Patient
A4	Experiencer T28 Patient
A5	Experiencer T32 Other
A6	Experiencer T30 Patient
A7	Experiencer T33 Patient
A8	Experiencer T34 Other
A9	Experiencer T35 Patient
A10	Experiencer T37 Patient
